Company Overview and News

19
Rare auction showdown could decide fate of broadcaster Sky

13h theedgemarkets
LONDON (Sept 20): A protracted US$34 billion bidding war for European broadcaster Sky between US rivals Comcast and Twenty-First Century Fox is likely to be settled by a quick-fire auction on Saturday.
FOX HRGLY RDS.B RDS.A RDSB RDSA HL 500470 TTST TATASTEEL TATLY HRGLF RYDBF RYDAF FOXA DIS

18
Quick-fire auction may settle Sky bidding war

14h livemint
London: A protracted $34 billion bidding war for European broadcaster Sky between US rivals Comcast and Twenty-First Century Fox could be settled by a quick-fire auction on Saturday, UK regulators said on Thursday.
FOX 500470 TTST TATASTEEL TATLY FOXA DIS

19
Rare auction showdown could decide fate of broadcaster Sky

14h channelnewsasia
Britain's takeover regulator said on Thursday that the battle between Comcast and Twenty-First Century Fox for Sky Plc would now go to an auction procedure.
FOX HRGLY RDS.B RDS.A RDSB RDSA HL 500470 TTST TATASTEEL TATLY HRGLF RYDBF RYDAF FOXA DIS

19
Rare auction showdown could decide fate of broadcaster Sky

14h reuters
LONDON (Reuters) - A protracted $34 billion bidding war for European broadcaster Sky (SKYB.L) between U.S. rivals Comcast (CMCSA.O) and Twenty-First Century Fox (FOXA.O) is likely to be settled by a quick-fire auction on Saturday.
FOX HRGLY RDS.B RDS.A RDSB RDSA HL 500470 TTST TATASTEEL TATLY HRGLF RYDBF RYDAF FOXA DIS

19
Rare quick-fire auction could settle fate of broadcaster Sky

17h channelnewsasia
Britain's takeover regulator said on Thursday that the battle between Comcast and Twenty-First Century Fox for Sky Plc would now go to an auction procedure.
FOX RDS.B RDS.A RDSB RDSA 500470 TTST TATASTEEL TATLY RYDBF RYDAF FOXA DIS

19
Rare quick-fire auction could settle fate of broadcaster Sky

18h reuters
LONDON (Reuters) - A protracted $34 billion bidding war for European broadcaster Sky (SKYB.L) between U.S. rivals Comcast (CMCSA.O) and Twenty-First Century Fox (FOXA.O) could be settled by a quick-fire auction on Saturday, UK regulators said on Thursday.
FOX RDS.B RDS.A RDSB RDSA 500470 TTST TATASTEEL TATLY RYDBF RYDAF FOXA DIS

 
Thyssenkrupp to keep on implementing steel JV with Tata Steel: CEO

18h livemint
Duisburg, Germany: Thyssenkrupp’s interim chief executive dismissed speculation that it would pull out of its steel joint venture with Tata Steel in the wake of management upheaval at the German industrial conglomerate.
500470 TTST TATASTEEL TATLY

 
Thyssenkrupp to keep on implementing steel JV with Tata: CEO

18h moneycontrol
Thyssenkrupp's interim chief executive dismissed speculation that it would pull out of its steel joint venture with Tata Steel in the wake of management upheaval at the German industrial conglomerate.
500470 TTST TATASTEEL TATLY

 
Asian markets follow global shares higher, trade war still in focus

2018-09-20 thehindubusinessline
Asian stocks rose in early trade on Thursday following a second day of gains on global share markets amid easing investor concern over the impact from the US-China trade war, but markets remained cautious.
500470 TTST TATASTEEL TATLY

 
HFCL order from BSNL bodes well

2018-09-19 thehindubusinessline
HFCL has received an advance purchase order worth ₹611 crore from BSNL for broadband connectivity in Madhya Pradesh. The contract is for survey, procurement, supply, trenching, laying, installation, testing and maintenance of optical fibre cable, accessories and GPON equipment in the State under the Centre’s BharatNet programme, HFCL said. The material cost and service cost are ₹207 crore and ₹245 crore, respectively.
500470 TTST TATASTEEL TATLY

 
Will Mexico foray fuel TVS Motor Co?

2018-09-19 thehindubusinessline
TVS Motor Company on Wednesday announced a partnership with Torino Motors, a leading distributor of automobiles in Mexico, to strengthen its presence there. Under this partnership, in the first year, Torino Motors, a subsidiary of Groupo Autofin, will open 40 exclusive stores for TVS Motor Co in Mexico for distribution of two-wheelers, the company said in a statement. Shareholders of TVS Motor Co will closely follow the development further.
532343 500470 TTST TVSMOTOR TATASTEEL TATLY

 
Newgen Software inks pact with Hewlett Packard

2018-09-19 thehindubusinessline
Newgen Software Technologies has executed an agreement with Hewlett Packard Enterprise India Private Ltd for supply of software licences and related services. The size of the work order is about ₹78.85 crore and the project involves supply of new licences, renewal of annual technical support, upgrade and migration of existing software, software customisation services and application support. The order will run for is seven years.
500470 TTST TATASTEEL TATLY

 
Broker's call

2018-09-19 thehindubusinessline
Over the past one year, NBCC, in no uncertain terms, has lost its flavour. The stock is down over a third, when the sector’s median performance is down only by a tenth. True, NBCC faces uncertainty in critical projects. The worst, however, is priced in. But the street is missing the bigger picture: for a company of ₹80,000 crore order backlog, there are too many moving parts. Add another ₹20,000-25,000 crore expected as order inflow, accretion to backlog is clear on cards.
500470 TTST TATASTEEL TATLY

 
CCI imposes fine on Bajaj Hindusthan Sugar

2018-09-19 thehindubusinessline
Bajaj Hindusthan Sugar on Wednesday said the Competition Commission of India has imposed a penalty of ₹12.35 crore for alleged contravention of provisions of the Competition Act. The order relates to a joint tender floated by oil marketing companies for supply of ethanol. “Based on the company’s own assessment and advice given by its legal counsels, the company believes that it has a good case for succeeding in appeal and will accordingly file its appeal against the Order before the appropriate authority,” Bjaja Hindusthan said in a statement.
BAJAJHIND 500470 TTST TATASTEEL TATLY 500032

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...